MarketPulse

pre-funded warrants

8 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Ispecimen Inc.

iSpecimen Raises $2.5M via Private Placement to Bolster Operations

$ISPC raises $2.5M through private placement at $5.12/share. Proceeds target working capital and marketing expansion.
ISPCprivate placementcommon stock
BenzingaBenzinga··Not Specified

Oruka Therapeutics Plans $500M Capital Raise via Public Offering

Oruka Therapeutics plans $500M public offering plus $75M underwriter option to fund monoclonal antibody pipeline for psoriasis and inflammatory conditions.
ORKAmonoclonal antibodypublic offering
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Greenlane Holdings Signals Growth with Strategic Warrant Conversions and Extended Lock-Up

Greenlane Holdings announces warrant conversions by Berachain Investment Corporation and extended lock-up of board member Strategic Advisor Warrants through April 2027, signaling strategic confidence.
GNLNpre-funded warrantsbeneficial ownership
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Aureus Greenway Closes $9M Private Placement to Fund Autonomous Power Merger

Aureus Greenway (AGH) closes $9M private placement, issuing 3M shares at $3/share to fund working capital and proposed Autonomous Power Corporation merger.
AGHprivate placementcommon stock
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Xenon Pharma Raises $650M in Upsized Offering to Fund Pipeline Growth

Xenon Pharmaceuticals prices $650M upsized offering at $57/share with 10.5M shares. Proceeds fund pipeline acceleration; closes March 2026.
XENEpublic offeringcapital raise
GlobeNewswire Inc.GlobeNewswire Inc.··Maia Biotechnology, Inc.

MAIA Biotech Taps Capital Markets for Cancer Drug Development Push

MAIA Biotechnology launches underwritten public offering of common stock and pre-funded warrants to fund clinical trials for its lead cancer therapy ateganosine.
MAIAclinical developmentpublic offering
BenzingaBenzinga··Prnewswire

Ideal Power Secures $14M in Capital to Accelerate B-TRAN Commercialization

Ideal Power raised $14M to commercialize its B-TRAN semiconductor technology, funding customer design-ins, partnerships, and production infrastructure.
IPWRinstitutional investorsfinancing
GlobeNewswire Inc.GlobeNewswire Inc.··Digital Brands Group, Inc.

Digital Brands Group Holders Agree to Convertible Share Restrictions Through 2026

Digital Brands Group Series D holders voluntarily restrict convertible share conversions through May 2026, with phased disposal provisions thereafter to manage equity stability.
DBGIpre-funded warrantsSeries D Preferred Stock